Clinical trial

Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in…

NCT00149903 · Novartis Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00149903
Title Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients
Official title Multicenter, Double-blind, Randomized, Parallel Group Study on Efficacy and Safety of Enteric-coated Mycophenolate Sodium vs. Mycophenolate Mofetil in de Novo Chinese Renal Transplant Recipients
Lead sponsor Novartis Pharmaceuticals, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Renal Transplant
Intervention type Drug
Interventions Mycophenolate sodium (enteric coated)
Enrollment 300
Start date Jan 1, 2005
Primary completion Jun 1, 2006
First posted Sep 8, 2005
Last update posted Nov 18, 2016
Countries China

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies